CA72-4 and CEA in serum and peritoneal washing in gastric cancer;CA72-4 e CEA no soro e no lavado peritonial de doentes com câncer gástrico

Arquivos de Gastroenterologia

Volumn 39, Issue 1, 2002, Pages 17-21

  Mandorwski, Sandra ^a   Lourenço, Laércio Gomes ^a   Forones, Nora Manoukian ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Disciplina de Gastroenterologia   (Brazil)

Author keywords

Antigens; Biological; Carbohydrate; Carcinoembryonic antigen; Peritoneal lavage; Stomach neoplasms; Tumor markers; Tumor associated

Indexed keywords

CA 72-4 ANTIGEN; CARBOHYDRATE; CARCINOEMBRYONIC ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER; CA 72 4 ANTIGEN; CA-72-4 ANTIGEN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN CELL; LAPAROTOMY; MALE; PERITONEUM LAVAGE; PROGNOSIS; REFERENCE VALUE; ROC CURVE; SENSITIVITY AND SPECIFICITY; STOMACH ADENOCARCINOMA; STOMACH CANCER; AGED; BLOOD; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PERITONEAL LAVAGE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS;

EID: 0037732610     PISSN: 00042803     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-28032002000100004     Document Type: Article

References (24)

1. Asao T, Fukuda T, Yazawa S, Nagamachi Y. Carcinoembrionic antigen levels in peritoneal washings can predict peritoneal recurrence after curative resection of gastric cancer. Cancer 1991;68:44-7.
2. Atiq OT, Kelsen DP, Shiu MH, Saltz L, Tong W, Nieddzwiecki D. Phase chemotherapy in patients with resected gastric cancer. J Clin Oncol 1993;11:425.
3. Burke EC, Karpeh MS, Conlon KC, Brenan MP. Peritoneal lavage cytology in gastric cancer: an independent predictor of outcome. Ann Surg Oncol 1998;5:411-5.
4. Cooper EH, Mello JP, Giles GR. Biochemical markers in gastro-intestinal malignancies. Arq Gastroenterol 1989;26:131-40.
5. Estape J, Grau JL, Leobendas F, Curto J, Daniels M, Vinola N, Pia C. Mitomycin C as an adjuvant treatment to resected gastric cancer; a 10 year follow-up. Ann Surg 1991;213:219-21.
6. Fernandez-Fernandez L, Tejero E, Tieso A, Rabadan L, Munoz M, Santos I. Receiver operating characteristic (ROC) curve analysis of the tumor markers CEA, CA19-9 and CA72-4 in gastric cancer. Int Surg 1996;81:400-2.
7. Filella X, Fuster J, Molina R, Garcia-Valdeeasas JC, Grande L, Estapé J, Ballesta AM. TAG-72, CA 19-9 and CEA as tumor markers in gastric cancer. Acta Oncol 1994;33:747-51.
8. Ikeda Y, Oomori H, Koyanagi N, Mori M, Kamakura T. Prognostic value of combination assays for CEA and CA19-9 in gastric cancer. Oncology 1995;52:483-6.
9. Ikegushi M, Katano K, Saitou H, Tsujitani S, Macta M, Kaibara N. Pre-operative serum levels of CA72-4 in patients with gastric adenocarcinoma. Hepatogastroenterology 1997;44:866-71.
10. Instituto Nacional do Câncer. Estimativa de incidência e mortalidade por câncer no Brasil. 2000. Disponivel em: http://www.org.br.
11. Irinoda T, Terashima M, Takane A, Sasaki N, Abe K, Araya M, Nishizuka S, Yonezawa H, Nakaya T, Shimooki O, Oyama K, Ikeda K, Saito K. Carcinoembryonic antigen level in peritoneal washing is a prognostic factor in patients with gastric cancer. Oncol Rep 1998;5:661-6.
12. Janssen CW, Orjasate H. CEA in patients with gastric carcinoma. Eur J Surg Oncol 1986;12:19-23.
13. Kim JP, Kwon OJ, Oh ST, Yank HK. Results of surgery in 6,589 gastric cancer patients and immunochemotherapy as the best treatment of advanced gastric cancer patients. Ann Surg 1992;216:269-75.
14. Kodama I, Koufuji K, Kawabata S, Tetsu S, Tsuji Y, Takeda J, Kakegawa T. The clinical efficacy of CA72-4 as a serum marker for gastric cancer in comparison with CA19-9 and CEA. Int Surg 1995;80:45-8.
15. McInture RKR. Marcadores tumorales. In: Devita VT, Helleman S, Rosenberg SA. Cancer. 2. ed. Barcelona: Espanha Salvat; 1995. p.349-62.
16. Moor GE, Sako K, Kondo T, Badino J, Burke E. Assessment of the exfoliation of tumor cells into the body cavities. Surg Gynecol Obstet 1961;122:469-74.
17. Nakane Y, Okamura S, Akehira K, Boku T, Okusa T, Tanaka K, Hioki K. Correlation of preoperative CEA and prognosis of gastric cancer patients. Cancer 1994;73:2703-8.
18. Nishiyama M, Ikuhiro T, Takashi T, Yoshida Z, Toge T, Nagata N, Iwanori Y, Tamura S. Carcinoembryonic antigen levels in the peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer. World J Surg 1995;19:133-7.
19. Ribeiro Jr U, Gama-Rodrigues JJ, Safatle-Ribeiro AV, Bitelman B, Ibrahim RE, Ferreira MB, Laudanna AA, Pinotti HW. Prognostic significance of intraperitoneal free cancer cells obtained by laparoscopic peritoneal lavage in patients with gastric cancer. J Gastrointest Surg 1998;2:244-9.
20. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology - a basic science for clinical medicine. Boston: Little, Brown; 1991. p. 69-152.
21. Suzuki T, Ochiai T, Hayashi H, Nakajima K, Yasumoto A, Hishikawa E, Shimada H, Horiuchi F, Ohki S, Isono K. Importance of positive peritoneal lavage cytology findings in the stage grouping of gastric cancer. Surg Today 1999;29:111-5.
22. Thor A, Ohuchi N, Szpapak CA, Johnston WW, Schlom J. Distribution of oncofetal antigen tumor associated glicoprotein-72 defined by monoclonal antibody B-72.3. Cancer Res 1986;46:3118-24.
23. Victorzon M, Haglund C, Lundin J, Roberts PS. A prognostic value of CA 19-9 but not of CEA in patients with gastric cancer. Eur J Surg Oncol 1995;21:379-84.
24. Zweig MH, Campbell G. Receiver operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.